Albendazole is pregnancy category C. Data on the use of albendazole in pregnant women are limited, though the available evidence suggests no difference in congenital abnormalities in the children of women who were accidentally treated with albendazole during mass prevention campaigns compared with those who were not. In mass prevention campaigns for which the World Health Organization (WHO) has determined that the benefit of treatment outweighs the risk, WHO allows use of albendazole in the 2nd and 3rd trimesters of pregnancy. However, the risk of treatment in pregnant women who are known to have an infection needs to be balanced with the risk of disease progression in the absence of treatment.
Itching can be prevented only to the extent that the underlying cause(s) of the itching sensation can be prevented. For example, careful use of sunscreen products can prevent the itching associated with sunburn. Keeping well hydrated and using moisturizers can prevent the itch associated with dry skin. It is also possible to take preventive measures to avoid contagious conditions like sexually transmitted diseases, or tick or bug bites , or lice infestations that may be the sources of itching. Itching associated with serious conditions like skin cancers and liver or kidney disease cannot typically be prevented.